Abstract

Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the diagnosis and management of NPC, the Chinese Society of Clinical Oncology (CSCO) arranged a multi‐disciplinary team comprising of experts from all sub‐specialties of NPC to write, discuss, and revise the guidelines. Based on the findings of evidence‐based medicine in China and abroad, domestic experts have iteratively developed these guidelines to provide proper management of NPC. Overall, the guidelines describe the screening, clinical and pathological diagnosis, staging and risk assessment, therapies, and follow‐up of NPC, which aim to improve the management of NPC.

Details

Title
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
Author
Ling‐Long Tang 1   VIAFID ORCID Logo  ; Yu‐Pei Chen 1 ; Chuan‐Ben Chen 2 ; Ming‐Yuan Chen 3   VIAFID ORCID Logo  ; Nian‐Yong Chen 4 ; Xiao‐Zhong Chen 5 ; Xiao‐Jing Du 1 ; Wen‐Feng Fang 6 ; Feng, Mei 7 ; Gao, Jin 8 ; Han, Fei 1   VIAFID ORCID Logo  ; He, Xia 9 ; Chao‐Su Hu 10 ; De‐sheng Hu 11 ; Guang‐Yuan Hu 12 ; Jiang, Hao 13 ; Jiang, Wei 14 ; Feng, Jin 15 ; Jin‐Yi Lang 16 ; Jin‐Gao Li 17 ; Shao‐Jun Lin 2   VIAFID ORCID Logo  ; Liu, Xu 1 ; Qiu‐Fang Liu 18 ; Lin, Ma 19 ; Hai‐Qiang Mai 3   VIAFID ORCID Logo  ; Ji‐Yong Qin 20 ; Liang‐Fang Shen 21 ; Sun, Ying 1   VIAFID ORCID Logo  ; Pei‐Guo Wang 22 ; Ren‐Sheng Wang 23 ; Ruo‐Zheng Wang 24 ; Xiao‐Shen Wang 10 ; Wang, Ying 25 ; Wu, Hui 26 ; Yun‐Fei Xia 1 ; Shao‐Wen Xiao 27 ; Kun‐Yu Yang 28 ; Jun‐Lin Yi 29   VIAFID ORCID Logo  ; Xiao‐Dong Zhu 30 ; Ma, Jun 1   VIAFID ORCID Logo 

 Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat‐sen University Cancer Center, Guangzhou, Guangdong, P. R. China 
 Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Department of Radiation Oncology, Teaching Hospital of Fujian Medical University Provincial Clinical College, Cancer Hospital of Fujian Medical University, Fuzhou, Fujian, P. R. China 
 Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat‐sen University Cancer Center, Guangzhou, Guangdong, P. R. China 
 Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, P. R. China 
 Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, P. R. China 
 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Medical Oncology Department, Sun Yat‐Sen University Cancer Center, Guangzhou, Guangdong, P. R. China 
 Department of Radiation Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China 
 Department of Radiation Oncology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui, P. R. China 
 Department of Clinical Laboratory, Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, P. R. China 
10  Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, P. R. China 
11  Department of Radiotherapy, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China 
12  Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China 
13  Department of Radiation Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, P. R. China 
14  Department of Radiation Oncology, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, P. R. China 
15  Key Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, P. R. China 
16  Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China 
17  Department of Radiotherapy, Jiangxi Cancer Hospital, Nanchang, Jiangxi, P. R. China 
18  Department of Radiotherapy, Shaanxi Provincial Cancer Hospital Affiliated to Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi, P. R. China 
19  Department of Radiation Oncology, First Medical Center of Chinese PLA General Hospital, Beijing, P. R. China 
20  Department of Radiation Oncology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P. R. China 
21  Department of Radiation Oncology, Xiangya Hospital of Central South University, Changsha, Hunan, P. R. China 
22  Department of Radiotherapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China 
23  Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, P. R. China 
24  Department of Radiation Oncology, Key Laboratory of Oncology in Xinjiang Uyghur Autonomous Region, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P. R. China 
25  Department of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, P. R. China 
26  Department of Radiation Oncology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China 
27  Department of Radiotherapy, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, Haidian District, P. R. China 
28  Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China 
29  Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China 
30  Department of Radiotherapy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, P. R. China 
Pages
1195-1227
Section
GUIDELINES AND CONSENSUS
Publication year
2021
Publication date
Nov 2021
Publisher
John Wiley & Sons, Inc.
e-ISSN
2523-3548
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2602872012
Copyright
© 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.